The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
COHERUS BIOSCIENCES INC | COM | 19249H103 | 17,863 | 618,106 | SH | SOLE | 618,106 | 0 | 0 | ||
COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 3,157 | 176,976 | SH | SOLE | 176,976 | 0 | 0 | ||
ENERGY FUELS INC | COM NEW | 292671708 | 5,065 | 1,138,170 | SH | SOLE | 1,138,170 | 0 | 0 | ||
SABRE CORP | COM | 78573M104 | 22,495 | 945,157 | SH | SOLE | 945,157 | 0 | 0 | ||
VERACYTE INC | COM | 92337F107 | 3,915 | 351,435 | SH | SOLE | 351,435 | 0 | 0 | ||
XBIOTECH INC | COM | 98400H102 | 1,912 | 105,770 | SH | SOLE | 105,770 | 0 | 0 |